German 2-year bond yield falls as traders react to U.S. election-June 2024-www.financetom.com

Market

German 2-year bond yield falls as traders react to U.S. election

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

German 2-year bond yield falls as traders react to U.S. election

Nov 9, 2024 11:09 AM

LONDON, Nov 6 (Reuters) - Germany's 2-year bond yield

fell sharply in early trading on Wednesday as investors reacted

to a likely Donald Trump victory in the U.S. presidential

election, which could pave the way for higher tariffs that hurt

Europe's economy.

The German 2-year yield, which is sensitive to

European Central Bank interest rate expectations, was last down

8 basis points (bps) at 2.221%.

Previous page： US STOCKS-Futures slip after US plans tighter trade curbs; Nvidia falls Next page： Eupraxia Surges 15% in U.S. Pre-market Trading After Reporting Positive Data From Resolve Phase 1b/2a Trial

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

US STOCKS-Futures slip after US plans tighter trade curbs; Nvidia falls

Feb 25, 2025

(For a Reuters live blog on U.S., UK and European stock markets, click/ or type LIVE/ in a news window.) * Home Depot ( HD ) falls on downbeat annual same-store sales growth forecast * Zoom Communications ( ZM ) slips on bleak revenue outlook * Conference Board's gauge of consumer confidence due at 10 a.m. ET * Futures: Dow...

Eupraxia Surges 15% in U.S. Pre-market Trading After Reporting Positive Data From Resolve Phase 1b/2a Trial

Feb 25, 2025

08:03 AM EST, 02/25/2025 (MT Newswires) -- Eupraxia Pharmaceuticals ( EPRX ) rose 15% in U.S. pre-market trading on Tuesday after announcing additional positive clinical data from its Resolve Phase 1b/2a trial. The ongoing trial, which is evaluating EP-104GI for the treatment of eosinophilic esophagitis, an inflammatory disease of the esophagus, showed that histological scores and symptom scores continue to...

Stantec Up in U.S. Pre-market on Higher Dividend, Q4 Adjusted Earnings Beat

Feb 25, 2025

08:06 AM EST, 02/25/2025 (MT Newswires) -- Stantec ( STN ) traded 1.3% higher at last look Tuesday in NYSE pre-market trading as the company increased its dividend following a fourth-quarter adjusted earnings beat. The company will pay a dividend of $0.225 per share, a 7.1% increase, on April 15 to shareholders of record on March 28. The sustainable design...

Traders Eye Nvidia Earnings, Driving Muted Pre-Bell Action for US Equity Futures

Feb 25, 2025

08:18 AM EST, 02/25/2025 (MT Newswires) -- US equity futures were little changed pre-bell Tuesday, with investor sentiment largely muted ahead of crucial earnings results from chipmaker Nvidia ( NVDA ) later in the week. Nvidia ( NVDA ) is scheduled to release its quarterly earnings after the closing bell on Wednesday. Oil prices were lower, with front-month global benchmark...